PMID- 28216152 OWN - NLM STAT- MEDLINE DCOM- 20170704 LR - 20211204 IS - 1879-1220 (Electronic) IS - 0960-0760 (Linking) VI - 168 DP - 2017 Apr TI - 1,25-Dihydroxyvitamin-D3 prevents the development of diabetic cardiomyopathy in type 1 diabetic rats by enhancing autophagy via inhibiting the beta-catenin/TCF4/GSK-3beta/mTOR pathway. PG - 71-90 LID - S0960-0760(17)30041-9 [pii] LID - 10.1016/j.jsbmb.2017.02.007 [doi] AB - Diabetic cardiomyopathy (DCM) can increase the risk of heart failure and death in diabetic patients. However, no effective approaches are available to prevent its progression and development. Studies have shown that vitamin D is greatly implicated in cardiac hypertrophy and fibrosis, and there is a high prevalence of vitamin D deficiency in diabetic patients. In this study, we investigated whether 1,25-Dihydroxyvitamin-D3 (1,25D3) can improve DCM through a vitamin D receptor (VDR)-dependent mechanism associated with autophagy and the beta-catenin/T-cell factor/lymphoid enhancer factor (TCF4)/glycogen synthase kinase-3beta (GSK-3beta)/mammalian target of rapamycin (mTOR) pathway. In this study, streptozotocin (STZ)-induced type 1 diabetic rats were established and were treated with 1,25D3 and/or chloroquine and/or VDR gene silencing for 8 weeks before being sacrificed. Compared with untreated diabetic rats, 1,25D3 partly attenuated the myocardial hypertrophy and interstitial fibrosis, improved cardiac function and restored the impaired cardiac autophagy in diabetic rats, all of which were reversed by silencing the VDR gene in diabetic rats. In high-glucose cultured H9C2 cells, 1,25D3 increased autophagy in a dose-dependent manner. Besides, the beta-catenin/TCF4/GSK-3beta and mTOR signaling were activated both in diabetic rats and in high-glucose cultured H9C2 cells. Treatment with 1,25D3 inhibited the beta-catenin/TCF4/GSK-3beta and mTOR signaling in H9C2 cells, whereas co-treatment with lithium chloride (LiCl) reversed this situation and abolished the beneficial effect of 1,25D3 on autophagy. These data suggest that 1,25D3 may improve DCM in type 1 diabetic rats by modulating autophagy through the beta-catenin/TCF4/GSK-3beta and mTOR pathway. Vitamin D may exist as a new therapeutic target for the treatment of DCM. CI - Copyright (c) 2017 Elsevier Ltd. All rights reserved. FAU - Wei, Huili AU - Wei H AD - Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuan Jiagang, Yuzhong District, Chongqing 400016, China. Electronic address: whl880410@163.com. FAU - Qu, Hua AU - Qu H AD - Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuan Jiagang, Yuzhong District, Chongqing 400016, China. Electronic address: 276647689@qq.com. FAU - Wang, Hang AU - Wang H AD - Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuan Jiagang, Yuzhong District, Chongqing 400016, China. Electronic address: 373776507@qq.com. FAU - Ji, Baolan AU - Ji B AD - Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuan Jiagang, Yuzhong District, Chongqing 400016, China. FAU - Ding, Yao AU - Ding Y AD - Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuan Jiagang, Yuzhong District, Chongqing 400016, China. FAU - Liu, Dan AU - Liu D AD - Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuan Jiagang, Yuzhong District, Chongqing 400016, China. FAU - Duan, Yang AU - Duan Y AD - Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuan Jiagang, Yuzhong District, Chongqing 400016, China. FAU - Liang, Huimin AU - Liang H AD - Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuan Jiagang, Yuzhong District, Chongqing 400016, China. FAU - Peng, Chuan AU - Peng C AD - Laboratory of Lipid and Glucose Metabolism, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. FAU - Xiao, Xiaoqiu AU - Xiao X AD - Laboratory of Lipid and Glucose Metabolism, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. FAU - Deng, Huacong AU - Deng H AD - Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuan Jiagang, Yuzhong District, Chongqing 400016, China. Electronic address: denghuacong_111@163.com. LA - eng PT - Journal Article DEP - 20170217 PL - England TA - J Steroid Biochem Mol Biol JT - The Journal of steroid biochemistry and molecular biology JID - 9015483 RN - 0 (Ctnnb1 protein, rat) RN - 0 (DNA-Binding Proteins) RN - 0 (Tcf4 protein, rat) RN - 0 (Transcription Factor 4) RN - 0 (Transcription Factors) RN - 0 (beta Catenin) RN - EC 2.7.1.1 (mTOR protein, rat) RN - EC 2.7.11.1 (Glycogen Synthase Kinase 3 beta) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - FXC9231JVH (Calcitriol) RN - IY9XDZ35W2 (Glucose) SB - IM EIN - J Steroid Biochem Mol Biol. 2017 Nov;174:312-313. PMID: 29102300 MH - Animals MH - Autophagy/*drug effects MH - Blood Pressure MH - Calcitriol/*pharmacology MH - Cell Line MH - Cell Line, Tumor MH - DNA-Binding Proteins/metabolism MH - Diabetes Mellitus, Experimental/metabolism MH - Diabetes Mellitus, Type 1/metabolism MH - Diabetic Cardiomyopathies/*prevention & control MH - Dose-Response Relationship, Drug MH - Echocardiography MH - Gene Silencing MH - Glucose/metabolism MH - Glycogen Synthase Kinase 3 beta/metabolism MH - Male MH - Rats MH - Rats, Sprague-Dawley MH - *Signal Transduction MH - TOR Serine-Threonine Kinases/metabolism MH - Tissue Distribution MH - Transcription Factor 4 MH - Transcription Factors/metabolism MH - beta Catenin/metabolism OTO - NOTNLM OT - Autophagy OT - Diabetic cardiomyopathy OT - Type 1 diabetes OT - Vitamin D EDAT- 2017/02/22 06:00 MHDA- 2017/07/05 06:00 CRDT- 2017/02/21 06:00 PHST- 2016/11/04 00:00 [received] PHST- 2017/02/09 00:00 [revised] PHST- 2017/02/09 00:00 [accepted] PHST- 2017/02/22 06:00 [pubmed] PHST- 2017/07/05 06:00 [medline] PHST- 2017/02/21 06:00 [entrez] AID - S0960-0760(17)30041-9 [pii] AID - 10.1016/j.jsbmb.2017.02.007 [doi] PST - ppublish SO - J Steroid Biochem Mol Biol. 2017 Apr;168:71-90. doi: 10.1016/j.jsbmb.2017.02.007. Epub 2017 Feb 17.